FR2470599A1
(fr)
*
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
US5364620A
(en)
*
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
US4894240A
(en)
*
|
1983-12-22 |
1990-01-16 |
Elan Corporation Plc |
Controlled absorption diltiazem formulation for once-daily administration
|
EP0225085A1
(de)
*
|
1985-11-13 |
1987-06-10 |
ELAN CORPORATION, Plc |
Arzneiformulierung mit gesteuerter Absorption
|
US5286494A
(en)
*
|
1986-07-02 |
1994-02-15 |
Schering Aktiengesellschaft |
Medicinal agents with sustained action
|
FR2602423B1
(fr)
*
|
1986-08-08 |
1989-05-05 |
Ethypharm Sa |
Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
|
IT1197316B
(it)
*
|
1986-10-01 |
1988-11-30 |
Proter Spa |
Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
|
GB8702411D0
(en)
*
|
1987-02-03 |
1987-03-11 |
Zyma Sa |
Swellable pellets
|
DK173505B1
(da)
*
|
1987-02-20 |
2001-01-15 |
Pharmatec Internat S R L |
Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
|
US5622716A
(en)
*
|
1987-02-20 |
1997-04-22 |
Farmarc Nederland B.V. |
Process for preparing a retard product containing diltiazem for a single daily administration
|
CA1323833C
(en)
*
|
1987-04-28 |
1993-11-02 |
Yatindra M. Joshi |
Pharmaceutical compositions in the form of beadlets and method
|
US5219621A
(en)
*
|
1987-10-16 |
1993-06-15 |
Elan Corporation, Plc |
Methods of treatment with diltiazem formulations
|
US5336504A
(en)
*
|
1987-10-16 |
1994-08-09 |
Elan Corporation, Plc |
Diltiazem formulations and methods of treatment
|
NZ226575A
(en)
*
|
1987-10-16 |
1991-01-29 |
Elan Corp Plc |
Controlled release formulation containing cis-(+)-3-acetyloxy-5-(2-(dimethylamino)ethyl)-2,3 dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4(5h)one(diltiazem) and having a surrounding membrane
|
DE3737741A1
(de)
*
|
1987-11-06 |
1989-05-18 |
Goedecke Ag |
Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
|
IL88083A
(en)
*
|
1987-11-06 |
1992-11-15 |
Tanabe Seiyaku Co |
Controlled release pharmaceutical dosage form and its preparation
|
IE64726B1
(en)
*
|
1987-11-20 |
1995-08-23 |
Elan Corp Plc |
Pharmaceutical formulations for preventing drug tolerance
|
FR2623714B1
(fr)
*
|
1987-11-26 |
1990-04-20 |
Ethypharm Sa |
Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
|
JPH0791184B2
(ja)
*
|
1988-03-31 |
1995-10-04 |
田辺製薬株式会社 |
放出制御型製剤およびその製法
|
FR2630647B1
(fr)
*
|
1988-04-27 |
1991-08-16 |
Sanofi Sa |
Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
|
US5344657A
(en)
*
|
1988-04-27 |
1994-09-06 |
Elf Sanofi |
Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
|
US4859470A
(en)
*
|
1988-06-02 |
1989-08-22 |
Alza Corporation |
Dosage form for delivering diltiazem
|
US5122384A
(en)
*
|
1989-05-05 |
1992-06-16 |
Kv Pharmaceutical Company |
Oral once-per-day organic nitrate formulation which does not induce tolerance
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5000962A
(en)
*
|
1989-08-25 |
1991-03-19 |
Schering Corporation |
Long acting diltiazem formulation
|
US4992277A
(en)
*
|
1989-08-25 |
1991-02-12 |
Schering Corporation |
Immediate release diltiazem formulation
|
IE82916B1
(en)
*
|
1990-11-02 |
2003-06-11 |
Elan Corp Plc |
Formulations and their use in the treatment of neurological diseases
|
JP2558396B2
(ja)
*
|
1990-06-28 |
1996-11-27 |
田辺製薬株式会社 |
放出制御型製剤
|
US5286497A
(en)
*
|
1991-05-20 |
1994-02-15 |
Carderm Capital L.P. |
Diltiazem formulation
|
ZA923474B
(en)
*
|
1991-05-20 |
1993-01-27 |
Marion Merrell Dow Inc |
Diltiazem formulation
|
AU2016992A
(en)
*
|
1991-05-20 |
1992-12-30 |
Marion Laboratories, Inc. |
Multi-layered controlled release formulation
|
US5252337A
(en)
*
|
1991-06-25 |
1993-10-12 |
Eurand America, Inc. |
Controlled release calcium channel blocker microcapsules
|
US5288505A
(en)
*
|
1991-06-26 |
1994-02-22 |
Galephar P.R., Inc., Ltd. |
Extended release form of diltiazem
|
GB2258613B
(en)
*
|
1991-08-12 |
1996-01-10 |
Euro Celtique Sa |
Pharmaceutical diltiazem formulation
|
KR100221695B1
(ko)
*
|
1991-08-12 |
1999-09-15 |
그린 마틴, 브라이언 쥐 테슬리 |
약학적 구상 제형
|
GB9117361D0
(en)
*
|
1991-08-12 |
1991-09-25 |
Euro Celtique Sa |
Oral dosage form
|
US5229135A
(en)
*
|
1991-11-22 |
1993-07-20 |
Prographarm Laboratories |
Sustained release diltiazem formulation
|
US5407686A
(en)
*
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5523095A
(en)
*
|
1993-12-15 |
1996-06-04 |
Eastman Chemical Company |
Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends
|
US5536505A
(en)
*
|
1993-12-15 |
1996-07-16 |
Eastman Chemical Company |
Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends
|
US5834024A
(en)
*
|
1995-01-05 |
1998-11-10 |
Fh Faulding & Co. Limited |
Controlled absorption diltiazem pharmaceutical formulation
|
JP2535141B2
(ja)
*
|
1995-01-17 |
1996-09-18 |
中外製薬株式会社 |
フマル酸含有徐放性製剤
|
US5567441A
(en)
*
|
1995-03-24 |
1996-10-22 |
Andrx Pharmaceuticals Inc. |
Diltiazem controlled release formulation
|
FR2742660B1
(fr)
|
1995-12-22 |
1998-04-03 |
Ethypharm Lab Prod Ethiques |
Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
|
US5830503A
(en)
*
|
1996-06-21 |
1998-11-03 |
Andrx Pharmaceuticals, Inc. |
Enteric coated diltiazem once-a-day formulation
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
US6074669A
(en)
*
|
1997-01-20 |
2000-06-13 |
Ranbaxy Laboratories Limited |
Controlled drug delivery system for diltiazem
|
US6162463A
(en)
*
|
1997-05-01 |
2000-12-19 |
Dov Pharmaceutical Inc |
Extended release formulation of diltiazem hydrochloride
|
ATE322892T1
(de)
|
1997-07-02 |
2006-04-15 |
Euro Celtique Sa |
Stabilisierte tramadol formulierungen mit verzögerter freisetzung
|
US6066339A
(en)
*
|
1997-10-17 |
2000-05-23 |
Elan Corporation, Plc |
Oral morphine multiparticulate formulation
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
GB2340835B
(en)
*
|
1998-08-26 |
2003-01-15 |
Pvax Ploymers Ltd |
PVA-containing compositions
|
US20010055613A1
(en)
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
US6620439B1
(en)
*
|
2000-10-03 |
2003-09-16 |
Atul M. Mehta |
Chrono delivery formulations and method of use thereof
|
US6984402B2
(en)
|
2000-10-03 |
2006-01-10 |
Elite Laboratories, Inc. |
Chrono delivery formulations and method of treating atrial fibrillation
|
US6635274B1
(en)
|
2000-10-27 |
2003-10-21 |
Biochemics, Inc. |
Solution-based transdermal drug delivery system
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20040029959A1
(en)
*
|
2002-08-08 |
2004-02-12 |
John Devane |
Isosorbide mononitrate compositions and methods of their use
|
CA2496837A1
(en)
*
|
2002-09-09 |
2004-03-18 |
Biovail Laboratories Inc. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US6913768B2
(en)
*
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
US9107804B2
(en)
|
2002-12-10 |
2015-08-18 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
US20050013863A1
(en)
*
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
US8007826B2
(en)
|
2003-12-11 |
2011-08-30 |
Acorda Therapeutics, Inc. |
Sustained release aminopyridine composition
|
US20070190125A1
(en)
|
2004-03-03 |
2007-08-16 |
Constantine Georgiades |
Positioning feature for aiding use of film or strip product
|
US8354437B2
(en)
*
|
2004-04-09 |
2013-01-15 |
Acorda Therapeutics, Inc. |
Method of using sustained release aminopyridine compositions
|
JP5519906B2
(ja)
|
2004-04-22 |
2014-06-11 |
ハワード ジェイ. スミス アンド アソシエイツ ピーティーワイ エルティーディー |
肝臓疾患の支持療法
|
US20070224269A1
(en)
*
|
2004-06-10 |
2007-09-27 |
Rubino Orapin P |
Controlled Release Pharmaceutical Formulation
|
EA013474B1
(ru)
*
|
2005-06-16 |
2010-04-30 |
Форест Лэборэтериз, Инк. |
Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
|
AU2006269944A1
(en)
*
|
2005-07-19 |
2007-01-25 |
Inverseon, Inc. |
Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
|
ES2566395T3
(es)
*
|
2005-07-28 |
2016-04-12 |
Shire Llc |
Formulaciones/composiciones farmacéuticas de guanfacina adecuadas para dosis diaria única
|
US20070098746A1
(en)
*
|
2005-11-02 |
2007-05-03 |
Nichols William M |
Multi-layered coating technology for taste masking
|
US20070141151A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Silver David I |
Lansoprazole orally disintegrating tablets
|
ES2550035T3
(es)
*
|
2006-01-27 |
2015-11-04 |
Adare Pharmaceuticals, Inc. |
Sistemas de administración de fármacos que comprenden un agente de bloqueo selectivo de la serotonina 5-HT3 débilmente básico y ácidos orgánicos
|
AU2007211101B2
(en)
*
|
2006-01-27 |
2013-05-02 |
Adare Pharmaceuticals, Inc. |
Drug delivery systems comprising weakly basic drugs and organic acids
|
CA2645855C
(en)
|
2006-03-16 |
2015-02-03 |
Tris Pharma, Inc. |
Modified release formulations containing drug-ion exchange resin complexes
|
US8133506B2
(en)
*
|
2008-03-12 |
2012-03-13 |
Aptalis Pharmatech, Inc. |
Drug delivery systems comprising weakly basic drugs and organic acids
|
US20110003005A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Gopi Venkatesh |
Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
|
BR112015003120B1
(pt)
|
2012-08-15 |
2022-08-09 |
Tris Pharma , Inc |
Tablete mastigável de liberação estendida de metilfenidato e seu uso
|
CA2936748C
(en)
|
2014-10-31 |
2017-08-08 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
CN114425046B
(zh)
*
|
2021-12-16 |
2023-10-20 |
南通联亚药业股份有限公司 |
一种盐酸地尔硫卓缓释胶囊
|